Table 2 Presenting tumor characteristics between NAFLD, HBV and HCV.
NAFLD | HBV | HCV | P value | |
|---|---|---|---|---|
Within Milan (%) | 85 (68) | 79 (46) | 109 (69) | <0.0001 |
Within UCSF (%) | 100 (80) | 93 (55) | 128 (81) | <0.0001 |
Median first tumor size (cm) (IQR) | 2.9 (2–4.5) | 4 (2.4–7.6) | 3 (2.1–4.6) | 0.0003 |
Median tumor numbers (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.232 |
AFP-producers | 35 (35) | 111 (66) | 124 (76) | <0.0001 |
Most definitive therapy*, n (%): | ||||
OLT | 50 (40) | 19 (11) | 30 (19) | <0.001 |
Resection | 14 (11) | 37 (22) | 14 (9) | |
RFA | 26 (21) | 20 (12) | 24 (15) | |
TACE/Y-90 | 13 (10) | 27 (16) | 26 (15) | |
PEI | 0 (0) | 2 (1) | 6 (4) | |
Chemotherapy | 5 (4) | 14 (8) | 4 (3) | |
Supportive | 17 (14) | 51 (30) | 55 (35) | |
